国际标准期刊号: 2576-1447
Yoshi Lingappa
Cancer has long been one of the most challenging diseases, with its complex and heterogeneous nature making it complicated to develop effective treatments. However, recent advancements in the field of cancer genomics have revolutionized our understanding of the disease. Cancer genomics, the study of the genetic makeup of cancer cells, has presented an abundance of information about the genetic alterations causing the cancer development and progression. At its core, cancer is a disease of the genome, caused by genetic alterations that disrupt the intricate machinery governing cell growth and division. The advent of advanced sequencing technologies has enabled scientists to decode the genetic blueprints of tumors, revealing a wealth of information about the specific mutations and genomic alterations.